Born from one of Japan's most beloved traditional foods — natto, the fermented soybean dish with a distinctive stringy texture and bold flavor — nattokinase has emerged as one of the most compelling cardiovascular health ingredients of the 21st century. Discovered in 1980 by Dr. Hiroyuki Sumi at Sumi Pharmaceuticals (now a part of research institutions in Japan), this potent fibrinolytic enzyme directly dissolves fibrin, the protein mesh that forms blood clots, offering a natural mechanism for supporting healthy circulation. With cardiovascular disease remaining the leading cause of death globally and consumer demand for heart-health supplements accelerating, nattokinase represents a rapidly expanding market opportunity for forward-thinking formulators and brands.
Attribute Details Enzyme Name Nattokinase (subtilisin NAT) Source Organism Bacillus subtilis var. natto (natto bacterium) Substrate Fermented soybeans (Glycine max) — traditional natto fermentation Discovery 1980, Dr. Hiroyuki Sumi, Japan Enzyme Classification Serine protease (EC 3.4.21.62) Molecular Weight ~27,724 Da Optimal pH Activity pH 7.0–12.0 (broad alkaline range) Optimal Temperature Up to 50°C (heat-stable)
Nattokinase exerts its cardiovascular benefits through a direct and unique mechanism of action:
Direct fibrinolysis — Unlike many enzymes that work indirectly through the body's plasminogen activation pathway, nattokinase directly degrades fibrin, the structural protein of blood clots. This makes it one of the most potent naturally occurring fibrinolytic agents known.
Plasminogen activation — Nattokinase also enhances the body's endogenous fibrinolytic system by converting plasminogen to plasmin and increasing tissue plasminogen activator (t-PA) production.
ACE inhibition — Secondary activity includes mild angiotensin-converting enzyme (ACE) inhibition, contributing to healthy blood pressure maintenance.
Anti-platelet aggregation — Demonstrated ability to reduce platestick aggregation, complementing its fibrinolytic action.
Specification Activity (FU/g) Form Notes Standard 20,000 FU/g Powder Entry-level, cost-effective Premium 40,000 FU/g Powder Most popular specification High-Potency 80,000 FU/g Powder For concentrated formulas Ultra 100,000+ FU/g Powder Maximum potency for advanced formulations Enteric-Coated 40,000 FU/g Granules Stomach-acid resistant for enhanced bioavailability
FU = Fibrinolytic Units, the internationally recognized activity measurement standard for nattokinase
Each batch is rigorously tested for both potency and safety:
Test Parameter Specification Result Appearance Light yellow to white fine powder Conforms Odor Characteristic, mild Conforms Nattokinase Activity ≥ 40,000 FU/g 42,500 FU/g Moisture ≤ 5.0% 3.1% Heavy Metals ≤ 10 ppm 5.8 ppm Lead (Pb) ≤ 3.0 ppm 1.2 ppm Arsenic (As) ≤ 1.0 ppm 0.3 ppm Total Plate Count ≤ 1,000 CFU/g <10 CFU/g E. coli Not detected ND Salmonella Not detected ND Aflatoxins (B1, B2, G1, G2) Not detected ND Soy Allergen Present (soy-derived) Conforms
Nattokinase's defining property is its ability to directly degrade fibrin — a mechanism confirmed through both in vitro and in vivo studies. Research published in Frontiers in Nutrition (2022) demonstrated that oral administration of 2,000 FU nattokinase daily for 8 weeks significantly reduced fibrinogen levels and improved blood flow parameters in healthy adults. A meta-analysis in Pharmaceuticals (2023) reviewing 12 clinical trials concluded that nattokinase supplementation consistently showed positive effects on fibrinolytic markers without increasing bleeding risk at standard doses.
Multiple clinical studies have demonstrated nattokinase's blood pressure-lowering effects. A randomized, double-blind, placebo-controlled trial published in Frontiers in Cardiovascular Medicine (2022) found that 200 mg/day of high-potency nattokinase (4,000 FU) significantly reduced both systolic (−5.4 mmHg) and diastolic (−2.9 mmHg) blood pressure in hypertensive patients over 8 weeks. The mechanism involves ACE inhibition and improved endothelial function through enhanced nitric oxide bioavailability.
Nattokinase contributes to arterial health through multiple complementary pathways:
Fibrin degradation reduces the fibrin-rich plaques characteristic of early atherosclerosis
Lipid metabolism modulation — Animal studies show nattokinase reduces LDL oxidation and triglyceride levels
Endothelial protection — Improved nitric oxide production supports healthy blood vessel elasticity
A study in Biomedical Reports (2018) showed that nattokinase supplementation significantly reduced carotid intima-media thickness (a direct measure of arterial plaque) in subjects with subclinical atherosclerosis over 26 weeks.
The growing awareness of DVT risk — particularly among travelers, post-surgical patients, and those with sedentary lifestyles — has driven interest in nattokinase as a preventive supplement. While not a replacement for pharmaceutical anticoagulants, nattokinase's fibrinolytic activity provides a complementary natural approach to maintaining healthy venous circulation. Research in Journal of Cardiovascular Pharmacology supports its role in reducing thrombosis risk factors.
Emerging research links cardiovascular health to cognitive function — what's good for the heart is good for the brain. By supporting healthy cerebral blood flow and reducing micro-clot formation, nattokinase may contribute to cognitive maintenance. Preclinical studies suggest nattokinase can cross-compensate for impaired fibrinolysis in aging populations, potentially reducing the risk of vascular cognitive impairment (Journal of the American Geriatrics Society, 2021).
Cardiovascular health capsules — Stand-alone nattokinase products targeting the $15B+ heart health supplement market
Comprehensive heart formulas — Combined with CoQ10, omega-3, garlic extract, and hawthorn for multi-target cardiovascular support
Circulation support blends — Paired with ginkgo biloba, horse chestnut, and Diosmin for venous and arterial health
Blood pressure support — Combined with Hawthorn Extract, celery seed, and L-arginine for comprehensive BP management formulas
Travel wellness kits — Single-serve nattokinase for long-haul travelers concerned about DVT risk
Heart-health fortified foods — Encapsulated nattokinase for functional food applications (requires enteric protection)
Wellness beverages — Emerging category of cardiovascular-support functional drinks
Anti-aging topical formulations — Nattokinase's fibrinolytic activity has been explored for topical applications targeting microcirculation and skin firmness
Scalp health products — Improved microcirculation supports healthy hair follicle function
Adjunct cardiovascular research — Being studied as a complementary agent alongside conventional cardiovascular therapies
Sports recovery — Nattokinase's fibrinolytic and anti-inflammatory properties are being explored for exercise-induced micro-trauma recovery
Veterinary applications — Cardiovascular support in companion animal health products
Nattokinase potency is measured in Fibrinolytic Units (FU) using the fibrin plate method — the globally recognized standard. Be wary of suppliers quoting potency in non-standard units. Every COA should clearly state activity in FU/g, verified by the fibrin plate assay. Independent laboratory verification (e.g., by JNKA — Japan Nattokinase Association) provides additional confidence.
Nattokinase is produced through controlled fermentation of soybeans using specific Bacillus subtilis natto strains. Key quality factors include:
Strain selection — Only specific natto-producing strains yield the desired subtilisin NAT enzyme
Fermentation conditions — Temperature, humidity, and time must be precisely controlled for consistent activity
Post-fermentation processing — Lyophilization (freeze-drying) preserves enzyme activity better than heat-based drying
While nattokinase is relatively heat-stable (active up to 50°C), it is susceptible to degradation by stomach acid (pH 1.5–3.5). This is why enteric-coated capsules are the preferred delivery format for maximum bioavailability. If your product is a standard capsule, ensure your formulation accounts for partial gastric degradation when calculating effective dosage.
Nattokinase is derived from fermented soybeans and contains soy proteins. This must be clearly disclosed on product labels for markets with allergen labeling requirements (US FDA, EU FIC, Australia/New Zealand). For soy-free formulations, research-grade non-soy nattokinase alternatives exist but are significantly more expensive and less commercially established.
Nattokinase has achieved important regulatory milestones:
Japan — Approved as a Food for Specified Health Use (FOSHU) for blood pressure claims
United States — GRAS status; marketed as a dietary supplement ingredient
Canada — Approved as a Natural Health Ingredient (NHI)
European Union — Status varies by member state; consult local regulations before market entry
China — Approved as a new food ingredient (新食品原料)
As an experienced botanical and enzyme ingredient supplier, we provide nattokinase products backed by rigorous quality standards and technical expertise:
Verified activity guarantees — Every batch tested by fibrin plate method, with FU activity clearly stated and guaranteed on the COA
Complete potency range — From 20,000 to 100,000+ FU/g, plus enteric-coated granules for optimized gastric delivery
GMP-certified production — ISO 22000, HACCP, Kosher, and Halal certified fermentation and processing facilities
Comprehensive documentation — COA (with FU activity verification), MSDS, TSE/BSE-free statement, allergen declaration, non-GMO certificate, and heavy metal/pesticide/microbiological reports — all provided with every shipment
Custom formulation support — Our technical team assists with dosage optimization, delivery format selection (standard vs. enteric-coated), and stability testing for your specific product format
Regulatory documentation packages — Pre-prepared regulatory support files for US, Japan, Canada, and Southeast Asian markets; customized documentation available for EU and other regions
Competitive pricing with stable supply — Direct fermentation capabilities and scale production ensure consistent quality and cost-competitive pricing across all potency levels
Technical consultation — Dedicated application scientists available for formulation guidance, stability studies, and clinical trial design support
Nattokinase stands as one of the most scientifically validated natural ingredients for cardiovascular health support. Its unique direct fibrinolytic mechanism, combined with growing clinical evidence for blood pressure support, circulatory health, and atherosclerosis prevention, makes it an essential component of any comprehensive heart-health product portfolio.
With global cardiovascular health supplement demand growing at 6–8% annually and nattokinase awareness accelerating in Western markets, there has never been a better time to introduce or expand nattokinase-based products.
Interested in Nattokinase? Contact us today for:
Current pricing and volume-based discounts
Free evaluation samples (standard 5–10g)
Custom potency specifications and enteric-coated options
Complete technical documentation and regulatory support packages
Our nattokinase specialists are ready to provide expert technical consultation, formulation support, and customized solutions to help you develop market-leading cardiovascular health products.